drugset / Trial / NCT04634812
Mass Balance Study of KBP-5074 in Healthy Male Subjects
NaSingle-groupOpen-labelBasic science
Summary
This is a Phase 1, open-label, nonrandomized, single-dose mass balance and metabolite identification study in healthy male subjects.
Timeline
- Start
- 2020-12-03
- Primary completion
- 2020-12-23
- Completion
- 2020-12-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ocedurenone | Small molecule | — | Oral |
Indications
No indication recorded.